Related Experiment Video

Updated: May 17, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Respiratory syncytial virus bronchiolitis in children

Judy Trivits Verger1, Emily Elizabeth Verger

  • 1Pediatric Critical Care and Neonatal Nurse Practitioner Programs, School of Nursing, Fagin Hall, 418 Curie Boulevard, University of Pennsylvania, Philadelphia, PA 19104, USA. jtv@nursing.upenn.edu

Critical Care Nursing Clinics of North America
|October 24, 2012
PubMed

Insights

Respiratory syncytial virus (RSV) management focuses on supportive care, including hydration, respiratory support, and in severe cases, mechanical ventilation. Palivizumab offers immunoprophylaxis for high-risk infants, while caregiver education is vital for infection risk reduction.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • Respiratory syncytial virus (RSV) is a common and highly infectious agent.
  • RSV frequently causes bronchiolitis, leading to significant morbidity and some mortality.
  • Effective management strategies are crucial for pediatric respiratory infections.

Purpose of the Study:

  • To outline the evidence-based management of respiratory syncytial virus infections.
  • To detail supportive care interventions for RSV.
  • To describe prophylactic and therapeutic options for RSV.

Main Methods:

  • Review of current clinical guidelines and evidence-based interventions for RSV.
  • Analysis of supportive care measures including hydration, nutrition, and respiratory support.
  • Evaluation of pharmacological and immunological treatments for RSV.

Main Results:

  • Supportive therapy is the cornerstone of RSV management.
  • Continuous positive airway pressure or mechanical ventilation may be required for severe cases.
  • Ribavirin is an option for severe RSV disease, and palivizumab provides immunoprophylaxis for high-risk infants.

Conclusions:

  • Comprehensive management of RSV involves supportive care, appropriate respiratory support, and targeted interventions.
  • Caregiver education on therapies and infection risk reduction is essential.
  • A multi-faceted approach is necessary to mitigate the impact of RSV in infants and children.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: